Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02152826 · ClinicalTrials.gov registry record · NA
Effectiveness of Two Water-Based Potassium Oxalate Desensitizers on Dental Hypersensitivity
A NA study, sponsored by Procter and Gamble.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT02152826 is a NA study that has completed, run by Procter and Gamble. The registered enrollment target is 80 participants.
The verdict
NCT02152826, a NA study, has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
This study will compare the safety and effectiveness of two water-based potassium oxalate desensitizers on existing dentinal hypersensitivity.
Interventions
- DEVICE Potassium oxalate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2014-03 |
| Est. Completion | 2014-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02152826
The ClinicalTrials.gov registry entry for NCT02152826 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Procter and Gamble, which has 70 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Potassium oxalate is the first listed.
NCT02152826 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02152826 about?
NCT02152826 is a clinical study titled "Effectiveness of Two Water-Based Potassium Oxalate Desensitizers on Dental Hypersensitivity". This study will compare the safety and effectiveness of two water-based potassium oxalate desensitizers on existing dentinal hypersensitivity.
What is the current status of trial NCT02152826?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2014-03. Estimated completion is 2014-09.
What interventions are being tested in trial NCT02152826?
The interventions under investigation include: Potassium oxalate (DEVICE).
Who is sponsoring clinical trial NCT02152826?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.